158 related articles for article (PubMed ID: 32436411)
1. Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum.
Park JH; Ryu SI; Kim IH
J Cosmet Laser Ther; 2020 Apr; 22(3):141-145. PubMed ID: 32436411
[TBL] [Abstract][Full Text] [Related]
2. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
[TBL] [Abstract][Full Text] [Related]
3. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
Fusade T
Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of laser therapy in xanthelasma palpebrarum.
Nguyen AH; Vaudreuil AM; Huerter CJ
Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
[TBL] [Abstract][Full Text] [Related]
5. Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum.
Balevi A; Ustuner P; Ozdemir M
J Cosmet Laser Ther; 2017 Apr; 19(2):100-105. PubMed ID: 27849400
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Efficacy and Safety of Fractional Carbon Dioxide Laser and Fractional Er:YAG Laser for the Treatment of Xanthelasma Palpebrarum: A Two-Center Randomized Split-Face Controlled Trial.
Tuan H; Chen Y; Yang S; Liu D; Chen D; Zhao Y
Photobiomodul Photomed Laser Surg; 2021 Feb; 39(2):131-136. PubMed ID: 33449843
[No Abstract] [Full Text] [Related]
7. Comparison of the efficacy and safety of continuous CO
Konstantinou MP; Evangelou G; Hegazy S; Krasagakis K; Bulai-Livideanu C
Int J Dermatol; 2023 Mar; 62(3):e120-e122. PubMed ID: 36318641
[No Abstract] [Full Text] [Related]
8. Is Q-switched neodymium-doped yttrium aluminium garnet laser an effective approach to treat xanthelasma palpebrarum? Results from a clinical study of 76 cases.
Karsai S; Schmitt L; Raulin C
Dermatol Surg; 2009 Dec; 35(12):1962-9. PubMed ID: 19708874
[TBL] [Abstract][Full Text] [Related]
9. Erbium: YAG laser ablation versus 70% trichloroacetıc acid application in the treatment of xanthelasma palpebrarum.
Güngör S; Canat D; Gökdemir G
J Dermatolog Treat; 2014 Aug; 25(4):290-3. PubMed ID: 23441855
[TBL] [Abstract][Full Text] [Related]
10. Fractional CO
Al-Kady NA; Hamdino M; Abdel Kawy FAW
J Cosmet Dermatol; 2021 Mar; 20(3):763-768. PubMed ID: 32892481
[TBL] [Abstract][Full Text] [Related]
11. Continuous Wave Potassium Titanyl Phosphate Laser Treatment is Safe and Effective for Xanthelasma Palpebrarum.
Greijmans E; Luiting-Welkenhuyzen H; Luijks H; Bovenschen HJ
Dermatol Surg; 2016 Jul; 42(7):860-6. PubMed ID: 27227474
[TBL] [Abstract][Full Text] [Related]
12. Split lesion randomized comparative study between long pulsed Nd:YAG laser 532 and 1,064 nm in treatment of facial port-wine stain.
Al-Dhalimi MA; Al-Janabi MH
Lasers Surg Med; 2016 Nov; 48(9):852-858. PubMed ID: 27669109
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of long-pulsed 1064 nm Nd:YAG laser treatment of basal cell carcinoma: A retrospective review.
Ahluwalia J; Avram MM; Ortiz AE
Lasers Surg Med; 2019 Jan; 51(1):34-39. PubMed ID: 30508262
[TBL] [Abstract][Full Text] [Related]
14. A Clinical and Dermatoscopic Perspective of the Efficacy and Safety of Erbium: YAG Laser Ablation Versus 50% Trichloroacetic Acid for the Management of Xanthelasma Palpebrarum.
Arora A; Mohta A; Mehta RD; Ghiya BC; Soni P; Jangir VK; Yadav MK; Khokhar R; Mangava V
J Cutan Aesthet Surg; 2024; 17(1):1-6. PubMed ID: 38736854
[TBL] [Abstract][Full Text] [Related]
15. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota.
Chan HH; Ying SY; Ho WS; Kono T; King WW
Dermatol Surg; 2000 Oct; 26(10):919-22. PubMed ID: 11050493
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the 532-nm KTP and 1064-nm Nd:YAG lasers for the treatment of cherry angiomas.
Pancar GS; Aydin F; Senturk N; Bek Y; Canturk MT; Turanli AY
J Cosmet Laser Ther; 2011 Aug; 13(4):138-41. PubMed ID: 21689029
[TBL] [Abstract][Full Text] [Related]
17. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial.
Esmat SM; Elramly AZ; Abdel Halim DM; Gawdat HI; Taha HI
Dermatol Surg; 2014 Dec; 40(12):1349-55. PubMed ID: 25380092
[TBL] [Abstract][Full Text] [Related]
18. 1064-nm Q-switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population.
Zhao Y; Wen CM; Zhou NN; Feng Q; Tu P
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2263-5. PubMed ID: 24909746
[No Abstract] [Full Text] [Related]
19. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
20. Xanthelasma palpebrarum: treatment with the erbium:YAG laser.
Borelli C; Kaudewitz P
Lasers Surg Med; 2001; 29(3):260-4. PubMed ID: 11573229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
